Verwandte Artikel zu Economic Evaluation of Cancer Drugs: Using Clinical...
Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data (Chapman & Hall/CRC Biostatistics Series) - Hardcover
Inhaltsangabe
The first book on the design and analysis of not only clinical trials but also how observational non-interventional data using clinical data is applied to economic evaluation and re-imbursement in the context of Cancer. This book is a non technical exposition of economic evaluation and no knowledge of advanced statistical methods is assumed.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Über die Autorin bzw. den Autor
Iftekhar Khan is a medical statistician and health economist and a lead statistician at Oxford Unviersity’s Center for Statistics in Medicine. Professor Khan is also a Senior Research Fellow in Health Economics at University of Warwick and is a Senior Statistical Assessor within the Licensing Division of the UK Medicine and Health Regulation Agency.
Ralph Crott is a former professor in Pharmacoeconomics at the University of Montreal in Quebec, Canada and former head of the EORTC Health Economics Unit and former senior health economist at the Belgian HTA organization.
Zahid Bashir has over twelve years experience working in the pharmaceutical industry in medical affairs and oncology drug development where he is involved in the design and execution of oncology clinical trials and development of reimbursement dossiers for HTA submission.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Gebraucht kaufen
Zustand: BefriedigendBefriedigend/Good: Durchschnittlich...
Diesen Artikel anzeigen
EUR 20,41
EUR 45,00 für den Versand von Deutschland nach USA
Versandziele, Kosten & DauerNeu kaufen
Diesen Artikel anzeigen
EUR 86,47
EUR 2,26 für den Versand innerhalb von/der USA
Versandziele, Kosten & Dauer
Suchergebnisse für Economic Evaluation of Cancer Drugs: Using Clinical...
Beispielbild für diese ISBN
Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data (Chapman & Hall/CRC Biostatistics Series)
Anbieter: medimops, Berlin, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Zustand: good. Befriedigend/Good: Durchschnittlich erhaltenes Buch bzw. Schutzumschlag mit Gebrauchsspuren, aber vollständigen Seiten. / Describes the average WORN book or dust jacket that has all the pages present. Bestandsnummer des Verkäufers M01498761305-G
Anzahl: 1 verfügbar
Beispielbild für diese ISBN
Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data (Chapman & Hall/CRC Biostatistics Series)
Anbieter: HPB-Red, Dallas, TX, USA
Verkäuferbewertung 5 von 5 Sternen
Hardcover. Zustand: Good. Connecting readers with great books since 1972! Used textbooks may not include companion materials such as access codes, etc. May have some wear or writing/highlighting. We ship orders daily and Customer Service is our top priority! Bestandsnummer des Verkäufers S_338433118
Anzahl: 1 verfügbar
Foto des Verkäufers
Economic Evaluation of Cancer Drugs : Using Clinical Trial and Real World Data
Anbieter: GreatBookPrices, Columbia, MD, USA
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. Bestandsnummer des Verkäufers 33183721-n
Anzahl: 1 verfügbar
Beispielbild für diese ISBN
Economic Evaluation of Cancer Drugs
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Bestandsnummer des Verkäufers GB-9781498761307
Anzahl: 2 verfügbar
Beispielbild für diese ISBN
Economic Evaluation of Cancer Drugs (Hardcover)
Verlag:
Taylor & Francis Inc, Portland, 2019
ISBN 10: 1498761305
ISBN 13: 9781498761307
Neu
Hardcover
Anbieter: Grand Eagle Retail, Bensenville, IL, USA
Verkäuferbewertung 5 von 5 Sternen
Hardcover. Zustand: new. Hardcover. Cancer is a major healthcare burden across the world and impacts not only the people diagnosed with various cancers but also their families, carers, and healthcare systems. With advances in the diagnosis and treatment, more people are diagnosed early and receive treatments for a disease where few treatments options were previously available. As a result, the survival of patients with cancer has steadily improved and, in most cases, patients who are not cured may receive multiple lines of treatment, often with financial consequences for the patients, insurers and healthcare systems. Although many books exist that address economic evaluation, Economic Evaluation of Cancer Drugs using Clinical Trial and Real World Data is the first unified text that specifically addresses the economic evaluation of cancer drugs. The authors discuss how to perform cost-effectiveness analyses while emphasising the strategic importance of designing cost-effectiveness into cancer trials and building robust economic evaluation models that have a higher chance of reimbursement if truly cost-effective. They cover the use of real-world data using cancer registries and discuss how such data can support or complement clinical trials with limited follow up. Lessons learned from failed reimbursement attempts, factors predictive of successful reimbursement and the different payer requirements across major countries including US, Australia, Canada, UK, Germany, France and Italy are also discussed. The book includes many detailed practical examples, case studies and thought-provoking exercises for use in classroom and seminar discussions. Iftekhar Khan is a medical statistician and health economist and a lead statistician at Oxford Unviersitys Center for Statistics in Medicine. Professor Khan is also a Senior Research Fellow in Health Economics at University of Warwick and is a Senior Statistical Assessor within the Licensing Division of the UK Medicine and Health Regulation Agency. Ralph Crott is a former professor in Pharmacoeconomics at the University of Montreal in Quebec, Canada and former head of the EORTC Health Economics Unit and former senior health economist at the Belgian HTA organization.Zahid Bashir has over twelve years experience working in the pharmaceutical industry in medical affairs and oncology drug development where he is involved in the design and execution of oncology clinical trials and development of reimbursement dossiers for HTA submission. The first book on the design and analysis of not only clinical trials but also how observational non-interventional data using clinical data is applied to economic evaluation and re-imbursement in the context of Cancer. This book is a non technical exposition of economic evaluation and no knowledge of advanced statistical methods is assumed. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. Bestandsnummer des Verkäufers 9781498761307
Anzahl: 1 verfügbar
Beispielbild für diese ISBN
Economic Evaluation of Cancer Drugs
Anbieter: PBShop.store US, Wood Dale, IL, USA
Verkäuferbewertung 5 von 5 Sternen
HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000. Bestandsnummer des Verkäufers GB-9781498761307
Anzahl: 2 verfügbar
Foto des Verkäufers
Economic Evaluation of Cancer Drugs : Using Clinical Trial and Real World Data
Anbieter: GreatBookPrices, Columbia, MD, USA
Verkäuferbewertung 5 von 5 Sternen
Zustand: As New. Unread book in perfect condition. Bestandsnummer des Verkäufers 33183721
Anzahl: 1 verfügbar
Beispielbild für diese ISBN
Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data (Chapman & Hall/CRC Biostatistics Series)
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. In. Bestandsnummer des Verkäufers ria9781498761307_new
Anzahl: Mehr als 20 verfügbar
Foto des Verkäufers
Economic Evaluation of Cancer Drugs : Using Clinical Trial and Real World Data
Anbieter: GreatBookPricesUK, Woodford Green, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. Bestandsnummer des Verkäufers 33183721-n
Anzahl: 2 verfügbar
Beispielbild für diese ISBN
Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data (Chapman & Hall/CRC Biostatistics Series)
Verlag:
Chapman and Hall/CRC 2019-06-28, 2019
ISBN 10: 1498761305
ISBN 13: 9781498761307
Neu
Hardcover
Anbieter: Chiron Media, Wallingford, Vereinigtes Königreich
Verkäuferbewertung 4 von 5 Sternen
Hardcover. Zustand: New. Bestandsnummer des Verkäufers 6666-GRD-9781498761307
Anzahl: 2 verfügbar